Arris, C E <br/><br/>
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles.  [electronic resource] 

 -  Journal of medicinal chemistry  Jul 2000 
 - 2797-804 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm990628o  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemical synthesis<br/>CDC2 Protein Kinase--antagonists & inhibitors<br/>CDC2-CDC28 Kinases<br/>Crystallography, X-Ray<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Drug Screening Assays, Antitumor<br/>Enzyme Inhibitors--chemical synthesis<br/>Humans<br/>Hydrogen Bonding<br/>Models, Molecular<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Purines--chemical synthesis<br/>Pyrimidines--chemical synthesis<br/>Structure-Activity Relationship<br/>Tumor Cells, Cultured